DNA vaccines against anthrax

Expert Opinion on Biological Therapy

Volumn 4, Issue 10, 2004, Pages 1661-1667

  Galloway, Darrell R ^a   Baillie, Les ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Anthrax; Bacillus anthracis; DNA vaccine; Genetic immunisation; Lethal factor; Protective antigen

Indexed keywords

ADJUVANT; AMINO ACID; ANTHRAX VACCINE; ANTIBIOTIC AGENT; ANTIBODY; BACTERIAL TOXIN; BUPIVACAINE; DNA VACCINE; IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; PLASMID DNA;

ANTHRAX; ANTIBODY RESPONSE; BACILLUS ANTHRACIS; BACTERIAL STRAIN; BIOLOGICAL WARFARE; CLINICAL FEATURE; DISEASE MODEL; DRUG INDICATION; GENE GUN; HUMAN; IMMUNIZATION; LETHAL GENE; MEDICAL RESEARCH; NONHUMAN; REVIEW; TREATMENT INDICATION; VACCINATION;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; BACILLUS ANTHRACIS; BIOTERRORISM; CATTLE; CATTLE DISEASES; DNA, BACTERIAL; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; MACACA MULATTA; MALE; MICE; PLASMIDS; RABBITS; VACCINATION; VACCINES, DNA;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

EID: 5644283342     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.4.10.1661     Document Type: Review

References (46)

1. CHRISTOPHER GW, CIESLAK TJ, PAVLIN JA, EITZEN EM: Biological warfare. A historical perspective. JAMA (1997) 278(5):412-417.
2. BAILLIE L, READ TD: Bacillus anthracis, a bug with attitude! Curr. Opin. Microbiol. (2001) 4:78-81.
3. READ TD, PETERSON SN, TOURASSE H et al.: The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature (2003) 423:81-86.
4. ROSS JM: The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Clin. Pathol. (1957) 73:485-494.
5. GUIDI-RONTANI C, WEBER-LEVY M, LABRUYERE E, MOCK M: Germination of Bacillus anthracis spores within alveolar macrophages. Mol. Microbiol. (1999) 31:9-17.
6. DIXON TC, MESELSON M, GUILLEMIN J, HANNA PC: Anthrax. N. Engl. J. Med. (1999) 341(11):815-826.
7. FRANZ DR, JAHRLING PB, FRIEDLANDER AM et al.: Clinical recognition and management of patients exposed to biological warfare agents. JAMA (1997) 278:399-411.
8. JERNIGAN JA, STEPHENS DS, ASHFORD DA et al.: Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. (2001) 7(6):933-944.
9. MOCK M, FOUET A: Anthrax. Annu. Rev. Microbiol. (2001) 55:647-671. A review of anthrax and associated disease mechanisms.
10. HOFFMASTER AR, RAVEL J, RASKO DA et al.: Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc. Natl Acad. Sci. USA (2004) 101:8449-8454. A significant paper describing the discovery of both wild-type and modified anthrax toxin genes in a close relative of B. anthracis.
11. SMITH H, KEPPIE J, STANLEY JL, HARRIS-SMITH PW: The chemical basis of the virulence of Bacillus anthracis. IV. Secondary shock as a major factor in the death of guinea pigs from anthrax. Br. J. Exp. Pathol. (1955) 36:323-327.
12. WELKOS S, FRIEDLANDER A, WEEKS S, LITTLE S, MENDELSON I: In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J. Med. Microbiol. (2002) 51(10):821-831.
13. TURNBULL PC: Current status of immunization against anthrax. Old vaccines may be here to stay for a while. Curr. Opin. Infect. Dis. (2000) 13:113-120.
14. BAILLIE L: The development of new vaccines against Bacillus anthracis. J. Appl. Microbiol. (2001) 91:609-613.
15. KOCH R: Mitt. Kaiserliche Gesundheitsamte (1881) 1:174-206.
16. PASTEUR L: De l'attenuation des virus et de leur retour a' la virulence. CR Acad. Sci. Agric. Bulg. (1881) 92:429-435.
17. TURNBULL PC: Anthrax vaccines: past, present and future. Vaccine (1991) 9:533-539.
18. WASSERMAN GM, GRABENSTEIN JD, PITTMAN PR et al.: Analysis of adverse events after anthrax immunization in US Army medical personnel. J. Occup. Environ. Med. (2003) 45(3):222-233.
19. JOELLENBECK L, ZWANZIGER LL, DURCH JS, STROM BL: The Anthrax Vaccine. Is it Safe? Does it Work? Joellenbeck L, Zwanziger LL, Durch JS, Strom BL (Eds), National Academy Press, Washington DC, USA (2002).
20. INGLESBY TV, O'TOOLE T, HENDERSON DA et al.: Anthrax as a biological weapon, 2002. Updated recommendations for management. JAMA (2002) 287(17):2236-2252.
21. DONNELLY JJ, ULMER JB, LIU MA: DNA vaccines. Dev. Biol. Stand (1998) 95:43-53.
22. TURNBULL PC, LEPPLA SH, BROSTER MG, QUINN CP, MELLING J: Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med. Microbiol. Immunol. (Berl.) (1988) 177:293-303.
23. GU ML, LEPPLA SH, KLINMAN DM: Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine (1999) 17(4):340-344. First paper to describe the use of DNA vaccination against anthrax.
24. WILLIAMSON ED, BEEDHAM RJ, BENNETT AM, MILLER J, BAILLIE LW: Presentation of the protective antigen of the mouse immune system: immune sequelae. J. Appl. Microbiol. (1999) 87(2):315-317.
25. PRICE BM, LINER AL, PARK S, LEPPLA SH, MATECZUN A, GALLOWAY DR: Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect. Immun. (2001) 69(7):4509-4515. First paper to demonstrate protection against anthrax by immunisation with LF.
26. TOWNSEND TJ, WlLLIAMSON ED, FLICK-SMITH H, REDMOND C, BAILLIE LW: DNA vaccination as prophylaxic against anthrax. (unpublished).
27. GALLOWAY D, LINER A, LEGUTKI J, MATECZUN A, BARNEWALL R, ESTEP J: Genetic immunization against anthrax. Vaccine (2004) 22:1604-1608. First paper to demonstrate DNA-based protective immunisation against inhalational anthrax in a significant rabbit model challenge, and confirmation of the protective effect of immunisation targeting the LF antigen.
28. HERMANSON G, WHITLOW V, PARKER S et al.: A cationic lipid formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. Proc. Natl. Acad. Sci. USA (2004) (In Press). Significant study demonstrating complete protection against inhalational anthrax in a rabbit model following formulated plasmid DNA-only immunisation, and confirmation of the protective effect of immunisation against the LF target antigen.
29. TUCKER SN, LIN K, STEVENS S, SCOLLAY R, BENNETT MJ, OLSON DC: Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland. Mol. Ther. (2003) 8:392-399.
30. RIEMENSCHNEIDER J, GARRISON A, GEISBERT J et al.: Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine (2003) 21:4071-4080.
31. WILLIAMSON ED, BENNETT AM, PERKINS SD, BEEDHAM RJ, MILLER J, BAILLIE LW: Co-immunization with a plasmid DNA cocktail primes mice against anthrax and plague. Vaccine (2002) 20(23-24):2933-2941.
32. HOOPER JW, THOMPSON E, WILHELMSEN C et al.: Smallpox vaccine protects nonhuman primates against lethal monkeypox. J. Virol. (2004) 78(9):5533-5543.
33. CHAPMAN G, LEGUTKI J, BRENNEMAN K et al.: Primate immune response to DNA vaccines encoding anthrax toxin components. ASM Biodefense Meeting. Baltimore, MD, USA (9-11 March 2004).
34. STRATFORD R, DOUCE G, ZHANG-BARBER L, FAIRWEATHER N, ESKOLA J, DOUGAN G: Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine (2001) 19:810-815.
35. OTTEN GR, DOE B, SCHAEFER M et al.: Relative potency of cellular and humoral immune responses induced by DNA vaccination. Intervirology (2000) 43:227-232.
36. JOHNSON PA, CONWAY MA, DALY J, NICOLSON C, ROBERTSON J, MILLS KH: Plasmid DNA encoding influenza virus hemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J. Gen. Virol. (2000) 81:1737-1745.
37. FISCHER L, MINKE J, DUFAY N, BAUDU P, AUDONNET JC: Rabies DNA vaccine in the horse: strategies to improve serological responses. Vaccine (2003) 21:4593-4596.
38. HARTIKKA J, BOZOUKOVA V, FERRARI M et al.: Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. Vaccine (2001) 19:1911-1923.
39. TAN Y, HACKETT NR, BOYER JL, CRYSTAL RG: Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen. Hum. Gene Ther. (2003) 14(17):1673-1682.
40. LEE JS, HADJIPANAYIS AG, WELKOS SL: Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge. Infect. Immun. (2003) 71(3):1491-1496.
41. BOSIO CM, MOORE BD, WARFIELD KL et al.: Ebola and Marburg virus-like panicles activate human myeloid dendritic cells. Virology (2004) 326(2):280-287.
42. WOLFF JA, MALONE RW, WILLIAMS P et al.: Direct gene transfer into mouse muscle in vivo. Science (1990) 247:1465-1468.
43. TANG DC, DE VIT M, JOHNSTON SA: Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 356:152-154.
44. ROBINSON HL, HUNT LA, WEBSTER RG: Protection against lethal influenza challenge by immunization with a haemagglutinin-expressing plasmid DNA vaccine. Vaccine (1993) 11:957-960.
45. DAVIS HL, MICHEL ML, WHALEN RG: DNA-based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum. Mol. Genet. (1993) 2:1847-1851.
46. WANG B, UGEN KE, SRIKANTAN V et al.: Gene inoculation generates immune responses against human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA (1993) 90:4156-4160.